166 related articles for article (PubMed ID: 11132240)
1. Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites.
Woodland C; Ito S; Granvil CP; Wainer IW; Klein J; Koren G
Life Sci; 2000 Nov; 68(1):109-17. PubMed ID: 11132240
[TBL] [Abstract][Full Text] [Related]
2. A tubule cell model for ifosfamide nephrotoxicity.
Aleksa K; Halachmi N; Ito S; Koren G
Can J Physiol Pharmacol; 2005 Jun; 83(6):499-508. PubMed ID: 16049550
[TBL] [Abstract][Full Text] [Related]
3. Renal ontogeny of ifosfamide nephrotoxicity.
Aleksa K; Halachmi N; Ito S; Koren G
J Lab Clin Med; 2004 Dec; 144(6):285-93. PubMed ID: 15614250
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity.
Aleksa K; Matsell D; Krausz K; Gelboin H; Ito S; Koren G
Pediatr Nephrol; 2005 Jul; 20(7):872-85. PubMed ID: 15875221
[TBL] [Abstract][Full Text] [Related]
5. Renal clearance of ifosfamide.
Springate J; Zamlauski-Tucker MJ; Lu H; Chan KK
Drug Metab Dispos; 1997 Sep; 25(9):1081-2. PubMed ID: 9311624
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.
Springate J; Chan K; Lu H; Davies S; Taub M
In Vitro Cell Dev Biol Anim; 1999 Jun; 35(6):314-7. PubMed ID: 10476917
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo.
Springate JE
J Appl Toxicol; 1997; 17(1):75-9. PubMed ID: 9048231
[TBL] [Abstract][Full Text] [Related]
8. New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity.
Storme T; Deroussent A; Mercier L; Prost E; Re M; Munier F; Martens T; Bourget P; Vassal G; Royer J; Paci A
J Pharmacol Exp Ther; 2009 Feb; 328(2):598-609. PubMed ID: 19017849
[TBL] [Abstract][Full Text] [Related]
9. Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.
Zaki EL; Springate JE; Taub M
Toxicol In Vitro; 2003 Aug; 17(4):397-402. PubMed ID: 12849722
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
Kurowski V; Wagner T
Cancer Chemother Pharmacol; 1997; 39(5):431-9. PubMed ID: 9054957
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin.
Kerbusch T; Jansen RL; Mathôt RA; Huitema AD; Jansen M; van Rijswijk RE; Beijnen JH
Clin Pharmacol Ther; 2001 Aug; 70(2):132-41. PubMed ID: 11503007
[TBL] [Abstract][Full Text] [Related]
12. Renal-tubule metabolism of ifosfamide to the nephrotoxic chloroacetaldehyde: pharmacokinetic modeling for estimation of intracellular levels.
Aleksa K; Ito S; Koren G
J Lab Clin Med; 2004 Mar; 143(3):159-62. PubMed ID: 15007305
[TBL] [Abstract][Full Text] [Related]
13. Enantioselective metabolism of ifosfamide by the kidney.
Aleksa K; Ito S; Koren G
Chirality; 2006 Jun; 18(6):398-405. PubMed ID: 16575879
[TBL] [Abstract][Full Text] [Related]
14. Investigation of ifosfamide nephrotoxicity induced in a liver-kidney co-culture biochip.
Choucha-Snouber L; Aninat C; Grsicom L; Madalinski G; Brochot C; Poleni PE; Razan F; Guillouzo CG; Legallais C; Corlu A; Leclerc E
Biotechnol Bioeng; 2013 Feb; 110(2):597-608. PubMed ID: 22887128
[TBL] [Abstract][Full Text] [Related]
15. Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo.
Brain EG; Yu LJ; Gustafsson K; Drewes P; Waxman DJ
Br J Cancer; 1998 Jun; 77(11):1768-76. PubMed ID: 9667645
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide clinical pharmacokinetics.
Wagner T
Clin Pharmacokinet; 1994 Jun; 26(6):439-56. PubMed ID: 8070218
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide, mesna, and nephrotoxicity in children.
Skinner R; Sharkey IM; Pearson AD; Craft AW
J Clin Oncol; 1993 Jan; 11(1):173-90. PubMed ID: 8418231
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide toxicity in cultured proximal renal tubule cells.
Springate J; Taub M
Pediatr Nephrol; 2007 Mar; 22(3):358-65. PubMed ID: 17072651
[TBL] [Abstract][Full Text] [Related]
19. Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation.
McCune JS; Risler LJ; Phillips BR; Thummel KE; Blough D; Shen DD
Drug Metab Dispos; 2005 Jul; 33(7):1074-81. PubMed ID: 15821045
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.
Kerbusch T; de Kraker J; Keizer HJ; van Putten JW; Groen HJ; Jansen RL; Schellens JH; Beijnen JH
Clin Pharmacokinet; 2001 Jan; 40(1):41-62. PubMed ID: 11236809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]